RxDoctor Payments Data

Jennifer Hannon

Family · Columbus, OHNPI 1700268018

Payments from drug & device makers

$2,122in general payments, 2019–2025

Across 121 payments — averaging $17.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$798
  • Medtronic$243
  • Collegium Pharmaceutical, Inc.$136
  • Biohaven Pharmaceuticals, Inc.$122
  • Biohaven Pharmaceutical Holding Company Ltd.$118
  • Pfizer$111
  • plus $595 from 16 others

What the payments were for

  • Food & beverage$2,10199%
  • Education$211%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,122 in reported general payments places this provider in the 80th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$14,874
Medicare patients
138
Services billed
328

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl19$16,081
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen446$10,864
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen333$8,829
Gabapentin507$7,296
Hysingla ErHydrocodone Bitartrate15$6,901
Fentanyl45$6,698
Oxycodone Hcl237$4,516
Pregabalin209$4,075
Lidocaine31$3,276
Tizanidine Hcl146$1,698
Morphine Sulfate ErMorphine Sulfate71$1,575
Tramadol Hcl232$1,124
Duloxetine Hcl40$961
Cyclobenzaprine Hcl126$927
Methadone Hcl61$875

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Hikma Pharmaceuticals USAMorphine Sulfate$50$72728 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,812 family providers in Ohio.

Other family in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →